The Efficacy and Safety of Initial Use of Irbesartan/Hydrochlorothiazide Fixed‐Dose Combination in Hypertensive Patients With and Without High Cardiovascular Risk

A post hoc pooled analysis of 2 multicenter, randomized, double‐blind, active‐controlled force‐titration studies assessed the antihypertensive efficacy and tolerability of 7 to 8 weeks' once‐daily fixed‐dose irbesartan/hydrochlorothiazide (HCTZ) 300/25 mg in 796 stage 1 or 2 hypertensive patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Hypertens (Greenwich)
Main Authors: Weir, Matthew R., Neutel, Joel M., Bhaumik, Amitabha, Obaldia, Maria Elena De, Lapuerta, Pablo
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Inc 2007
Assuntos:
Original Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110100/
https://ncbi.nlm.nih.gov/pubmed/18046109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2007.07805.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados